310 related articles for article (PubMed ID: 28386905)
21. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
[TBL] [Abstract][Full Text] [Related]
22. Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.
Decaup E; Duault C; Bezombes C; Poupot M; Savina A; Olive D; Fournié JJ
Immunol Lett; 2014 Sep; 161(1):133-7. PubMed ID: 24925024
[TBL] [Abstract][Full Text] [Related]
23. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
[TBL] [Abstract][Full Text] [Related]
24. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
Uldrich AP; Rigau M; Godfrey DI
Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
[TBL] [Abstract][Full Text] [Related]
25. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
[TBL] [Abstract][Full Text] [Related]
26. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Boutin L; Scotet E
Front Immunol; 2018; 9():828. PubMed ID: 29731756
[TBL] [Abstract][Full Text] [Related]
27. BTN3A1-antibodies and phosphoantigens: TCRVγ9Vδ2 "see" the difference.
Franchini DM; Michelas M; Lanvin O; Poupot M; Fournié JJ
Eur J Immunol; 2017 Jun; 47(6):954-957. PubMed ID: 28597565
[TBL] [Abstract][Full Text] [Related]
28. The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells.
Karunakaran MM; Herrmann T
Front Immunol; 2014; 5():648. PubMed ID: 25566259
[TBL] [Abstract][Full Text] [Related]
29. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
[TBL] [Abstract][Full Text] [Related]
30. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
[TBL] [Abstract][Full Text] [Related]
31. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells.
Wang H; Henry O; Distefano MD; Wang YC; Räikkönen J; Mönkkönen J; Tanaka Y; Morita CT
J Immunol; 2013 Aug; 191(3):1029-42. PubMed ID: 23833237
[TBL] [Abstract][Full Text] [Related]
32. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B
PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075
[TBL] [Abstract][Full Text] [Related]
33. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production.
Alice AF; Kramer G; Bambina S; Bahjat KS; Gough MJ; Crittenden MR
Sci Rep; 2021 Aug; 11(1):16347. PubMed ID: 34381163
[TBL] [Abstract][Full Text] [Related]
34. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.
Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ
Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779
[TBL] [Abstract][Full Text] [Related]
35. Division of labor and cooperation between different butyrophilin proteins controls phosphoantigen-mediated activation of human γδ T cells.
Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
Res Sq; 2023 Feb; ():. PubMed ID: 36824912
[TBL] [Abstract][Full Text] [Related]
36. Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells.
Gu S; Nawrocka W; Adams EJ
Front Immunol; 2014; 5():688. PubMed ID: 25657647
[TBL] [Abstract][Full Text] [Related]
37. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
[TBL] [Abstract][Full Text] [Related]
38. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
39. HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.
Kilcollins AM; Li J; Hsiao CH; Wiemer AJ
J Immunol; 2016 Jul; 197(2):419-28. PubMed ID: 27271567
[TBL] [Abstract][Full Text] [Related]
40. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response.
De Gassart A; Le KS; Brune P; Agaugué S; Sims J; Goubard A; Castellano R; Joalland N; Scotet E; Collette Y; Valentin E; Ghigo C; Pasero C; Colazet M; Guillén J; Cano CE; Marabelle A; De Bonno J; Hoet R; Truneh A; Olive D; Frohna P
Sci Transl Med; 2021 Oct; 13(616):eabj0835. PubMed ID: 34669444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
